| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |